Siren Morken

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Hôpital Bichat-Claude-Bernard(Current)

Aarhus University Hospital

Oslo University Hospital

University of Bergen

Aalborg University

Siren Morken is an author at Hôpital Bichat-Claude-Bernard specializing in palliative chemotherapy administration, endocrine tumor prognosis, and prognostic factors analysis.

ORCID

Publications per year

2023–2025

Publications

Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study

Halfdan Sørbye, Geir Olav Hjortland, Lene Weber Vestermark et al. · British Journal of Cancer · 2025 · 26 citations · Full text

Medicine, Oncology, Pathology +15

Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms

Siren Morken, Seppo W. Langer, Anna Sundlöv et al. · British Journal of Cancer · 2023 · 14 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

1–2 of 2